Table 2.
N | HPV positive (%) | P | PAX1 methylation | P | |
---|---|---|---|---|---|
Normal | 28 | 10 (36%) | 0 (0%) | ||
CIN1 | 32 | 26 (81%) | < 0.01 | 3 (9%) | < 0.01 |
CIN2/3 | 34 | 31 (91%) | < 0.05 | 15 (44%) | < 0.01 |
Cancer | 27 | 25 (92%) | 27 (100%) | < 0.01 |
*Cut-off-value of 4.1.
N | HPV positive (%) | P | PAX1 methylation | P | |
---|---|---|---|---|---|
Normal | 28 | 10 (36%) | 0 (0%) | ||
CIN1 | 32 | 26 (81%) | < 0.01 | 3 (9%) | < 0.01 |
CIN2/3 | 34 | 31 (91%) | < 0.05 | 15 (44%) | < 0.01 |
Cancer | 27 | 25 (92%) | 27 (100%) | < 0.01 |
*Cut-off-value of 4.1.